These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25492362)

  • 1. [Ketamine alters socially-evoked activity in the amygdala].
    Mihara T; Siegel SJ
    Nihon Yakurigaku Zasshi; 2014 Dec; 144(6):272-6. PubMed ID: 25492362
    [No Abstract]   [Full Text] [Related]  

  • 2. [Receptor antagonist of NMDA and animal models of schizophrenia].
    Bian SZ; Zhang J; Liu WL; Sun ZH; Gu ZL; Jiang XG
    Fa Yi Xue Za Zhi; 2009 Dec; 25(6):443-6. PubMed ID: 20225623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amygdala activity associated with social choice in mice.
    Mihara T; Mensah-Brown K; Sobota R; Lin R; Featherstone R; Siegel SJ
    Behav Brain Res; 2017 Aug; 332():84-89. PubMed ID: 28438555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?
    Large CH
    J Psychopharmacol; 2007 May; 21(3):283-301. PubMed ID: 17591656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxytocin reduces amygdala activity, increases social interactions, and reduces anxiety-like behavior irrespective of NMDAR antagonism.
    Sobota R; Mihara T; Forrest A; Featherstone RE; Siegel SJ
    Behav Neurosci; 2015 Aug; 129(4):389-98. PubMed ID: 26214213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative reinforcing strength of three N-methyl-D-aspartate antagonists with different onsets of action.
    Winger G; Hursh SR; Casey KL; Woods JH
    J Pharmacol Exp Ther; 2002 May; 301(2):690-7. PubMed ID: 11961074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methyl-4- isoxazoleproprionate (AMPA) glutamate-receptor antagonists have different interactions with the discriminative stimuli of abused drugs.
    Jackson A; Brown G; Stephens DN
    Psychopharmacology (Berl); 1996 Dec; 128(3):320-7. PubMed ID: 8972552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the 5-HT(3) receptor antagonist ondansetron on the ketamine- and dizocilpine-induced place preferences in mice.
    Suzuki T; Aoki T; Kato H; Yamazaki M; Misawa M
    Eur J Pharmacol; 1999 Dec; 385(2-3):99-102. PubMed ID: 10607864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.
    Anand A; Charney DS; Oren DA; Berman RM; Hu XS; Cappiello A; Krystal JH
    Arch Gen Psychiatry; 2000 Mar; 57(3):270-6. PubMed ID: 10711913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine.
    Duncan GE; Miyamoto S; Leipzig JN; Lieberman JA
    Brain Res; 1999 Oct; 843(1-2):171-83. PubMed ID: 10528123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia.
    Mohn AR; Gainetdinov RR; Caron MG; Koller BH
    Cell; 1999 Aug; 98(4):427-36. PubMed ID: 10481908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia.
    Meltzer HY; Rajagopal L; Huang M; Oyamada Y; Kwon S; Horiguchi M
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2181-94. PubMed ID: 24099265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of spontaneous tail-flicks in rats by blockade of transmission at N-methyl-D-aspartate receptors: roles of multiple monoaminergic receptors in relation to the actions of antipsychotic agents.
    Millan MJ; Gobert A; Bervoets K; Rivet JM; Veiga S; Brocco M
    J Pharmacol Exp Ther; 2000 Feb; 292(2):672-83. PubMed ID: 10640305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maslinic acid ameliorates NMDA receptor blockade-induced schizophrenia-like behaviors in mice.
    Jeon SJ; Kim E; Lee JS; Oh HK; Zhang J; Kwon Y; Jang DS; Ryu JH
    Neuropharmacology; 2017 Nov; 126():168-178. PubMed ID: 28899728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMDA receptor antagonists extend the sensitive period for imprinting.
    Parsons CH; Rogers LJ
    Physiol Behav; 2000 Mar; 68(5):749-53. PubMed ID: 10764906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ketamine administration, alone and in combination with E-6837, on climbing behavior.
    Briones-Aranda A; Suárez-Santiago JE; Picazo O; Castellanos-Pérez M
    Behav Pharmacol; 2016 Aug; 27(5):485-8. PubMed ID: 27035065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine and glycinamide prevent MK-801-induced deficits in the novel object recognition (NOR) test in the domestic rabbit (Oryctolagus cuniculus).
    Hoffman KL; Basurto E
    Behav Brain Res; 2014 Sep; 271():203-11. PubMed ID: 24933188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test.
    Ghasemi M; Raza M; Dehpour AR
    J Psychopharmacol; 2010 Apr; 24(4):585-94. PubMed ID: 19351802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The supramammillo-septal-hippocampal pathway mediates sensorimotor gating impairment and hyperlocomotion induced by MK-801 and ketamine in rats.
    Ma J; Leung LS
    Psychopharmacology (Berl); 2007 May; 191(4):961-74. PubMed ID: 17219218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of NMDA receptors in the nucleus accumbens elicits spontaneous tail-flicks in rats.
    Millan MJ; Audinot V; Honoré P; Bervoets K; Veiga S; Brocco M
    Eur J Pharmacol; 2000 Jan; 388(1):37-47. PubMed ID: 10657545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.